Reevaluating the safety profile of pediatrics: A comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment

Pediatrics

Volumn 121, Issue 5, 2008, Pages

  Ferranti, Jeffrey ^a,b   Horvath, Monica M ^b,c   Cozart, Heidi ^b   Whitehurst, Julie ^b   Eckstrand, Julie ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ADE surveillance; Adverse drug event; Pediatrics; Voluntary reporting

Indexed keywords

ACTIVATED CARBON; AMIKACIN; CYCLOSPORIN; DIGOXIN ANTIBODY F(AB) FRAGMENT; FENTANYL; FLUMAZENIL; GENTAMICIN; GLUCOSE; HEPARIN; HYDROCORTISONE; HYDROMORPHONE; ISONIAZID; METHOTREXATE; METRONIDAZOLE; MORPHINE; NALOXONE; OXCARBAZEPINE; PETHIDINE; PHENYTOIN; POLYSTYRENE; POTASSIUM; QUINIDINE; SODIUM; TACROLIMUS; THEOPHYLLINE; TOBRAMYCIN; VANCOMYCIN; VITAMIN K GROUP; WARFARIN; DRUG;

ADVERSE DRUG REACTION; ARTICLE; CHILD SAFETY; COMPARATIVE STUDY; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; HARM REDUCTION; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHODOLOGY; PEDIATRICS; PRIORITY JOURNAL; CHILD; DRUG SURVEILLANCE PROGRAM; MEDICATION ERROR; ORGANIZATION AND MANAGEMENT; RISK MANAGEMENT;

ADVERSE DRUG REACTION REPORTING SYSTEMS; CHILD; HUMANS; MEDICATION ERRORS; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; RISK MANAGEMENT;

EID: 44449172117     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-2609     Document Type: Article

References (25)

1. Institute of Medicine. To Err Is Human: Building a Safer Health System. Washington, DC: National Academy Press; 1999
2. Institute of Medicine. Patient Safety: Achieving a New Standard of Care. Washington, DC: National Academy Press; 2004
3. Institute of Medicine. Preventing Medication Errors: Quality Chasm Series. Washington, DC: National Academy Press; 2006
4. Resar RK, Rozich JD, Classen D. Methodology and rationale for the measurement of harm with trigger tools. Qual SafHealth Care. 2003;12(suppl 2):ii39-ii45
5. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA. 1995;274(1): 29-34
6. Bates DW, Miller EB, Cullen DJ, et al. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med. 1999;159(21):2553-2560
7. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266(20):2847-2851
8. Kilbridge PM, Classen DC. Automated surveillance for adverse events in hospitalized patients: back to the future. Qual Saf Health Care. 2006;15(3):148-149
9. Goldmann D, Kaushal R. Time to tackle the tough issues in patient safety. Pediatrics. 2002;110(4):823-826
10. Kaushal R, Bates DW, Landrigan C, et al. Medication errors and adverse drug events in pediatric inpatients. JAMA. 2001; 285(16):2114-2120
11. Bates DW, O'Neil A, Boyle D, et al. Potential identifiability and preventability of adverse events using information systems. J Am Med Informatics Assoc. 1994;1(5):404-411
12. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc. 1998;5(3):305-314
13. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II. N Engl J Med. 1991;324(6):377-384
14. Leape L, Lawthers, AG, Brennan, TA, Johnson, WG. Preventing medical injury. Qual Rev Bull. 1993;19(5):144-149
15. 15.Suresh G, Horbar JD, Plsek P, et al. Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics. 2004;113(6):1609-1618
16. Bates DW, Evans RS, Murff H, Stetson PD, Pizziferri L, Hripcsak G. Detecting adverse events using information technology. J Am Med Inform Assoc. 2003;10(2):115-128
17. Kilbridge P, Alexander, L, Ahmad A. Implementation of a system for computerized adverse drug even surveillance and intervention at an academic medical center. JCOM. 2006;12(2): 94-100
18. Kilbridge PM, Campbell UC, Cozart HB, Mojarrad MG. Automated surveillance for adverse drug events at a community hospital and an academic medical center. J Am Med Inform Assoc. 2006;13(4):372-377
19. Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795-801
20. Gurwitz JH, Field TS, Avorn J, et al. Incidence and prevent-ability of adverse drug events in nursing homes. Am J Med. 2000;109(2):87-94
21. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245
22. Rothman KJ. No adjustments are needed for multiple comparsons. Epidemiology. 1990;1(1):43-46
23. Raschke RA, Gollihare B, Wunderlich TA, et al. A computer alert system to prevent injury from adverse drug events: development and evaluation in a community teaching hospital [published correction appears in JAMA. 1999;281(5):420]. JAMA. 1998;280(15):1317-1320
24. Sharek PJ, Horbar JD, Mason W, et al. Adverse events in the neonatal intensive care unit: development, testing, and findings of an NICU-focused trigger tool to identify harm in North American NICUs. Pediatrics. 2006;118(4):1332-1340
25. Sharek PJ, Classen D. The incidence of adverse events and medical error in pediatrics. Pediatr Clin North Am. 2006;53(6): 1067-1077